Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program

Go back to Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
(NASDAQ: JAGX) Delayed: 0.99 -0.34 (25.56%)
Previous Close $1.33    52 Week High $4.60 
Open $1.33    52 Week Low $0.81 
Day High $1.33    P/E N/A 
Day Low $0.97    EPS $0.00 
Volume 147,521